April 2009
Volume 50, Issue 13
Free
ARVO Annual Meeting Abstract  |   April 2009
Intraindividual Comparison of Antibody Patterns in Sera and Aqueous Humor of Glaucoma Patients and Healthy Subjects
Author Affiliations & Notes
  • N. Boehm
    Dept of Ophthalmology, Experimental Eye Research, Mainz, Germany
  • U. Thiel
    Dept of Ophthalmology, Experimental Eye Research, Mainz, Germany
  • U. Lossbrandt
    Dept of Ophthalmology, Experimental Eye Research, Mainz, Germany
  • N. Pfeiffer
    Dept of Ophthalmology, Experimental Eye Research, Mainz, Germany
  • F. H. Grus
    Dept of Ophthalmology, Experimental Eye Research, Mainz, Germany
  • Footnotes
    Commercial Relationships  N. Boehm, None; U. Thiel, None; U. Lossbrandt, None; N. Pfeiffer, None; F.H. Grus, None.
  • Footnotes
    Support  Deutsche Forschungsgemeinschaft (Gr1463/4-1)
Investigative Ophthalmology & Visual Science April 2009, Vol.50, 2076. doi:
  • Views
  • Share
  • Tools
    • Alerts
      ×
      This feature is available to authenticated users only.
      Sign In or Create an Account ×
    • Get Citation

      N. Boehm, U. Thiel, U. Lossbrandt, N. Pfeiffer, F. H. Grus; Intraindividual Comparison of Antibody Patterns in Sera and Aqueous Humor of Glaucoma Patients and Healthy Subjects. Invest. Ophthalmol. Vis. Sci. 2009;50(13):2076.

      Download citation file:


      © ARVO (1962-2015); The Authors (2016-present)

      ×
  • Supplements
Abstract

Purpose: : In the past decade, multiple studies demonstrated changes in antibody profiles against ocular antigens in sera and aqueous humor of glaucoma patients. However, none of these studies directly compared serum versus aqueous humor antibody patterns in the same patients. Using protein-microarrays we analyzed antibody levels in both for intraindividual comparison. Additionally, we compared antibody reactivities from glaucoma patients and healthy subjects.

Methods: : Sera and aqueous humor of patients with primary open-angle glaucoma (POAG; n=13) and healthy controls (CTRL; n=13) were used for antibody analysis. The protein arrays were prepared by spotting 40 different purified antigens (known biomarkers from prior studies) onto nitrocellulose-coated slides. The arrays were incubated with sera (1:250) and aqueous humor (1:20) respectively. For visualization of the antibody-antigen-reactions arrays were treated with a fluorescence labeled anti-human IgG antibody, followed by fluorescence scanning. The signals emitted from secondary antibodies were digitized and the spot intensities were compared using multivariate statistical techniques.

Results: : The intraindividual comparison revealed congruences but also differences between antibody patterns of sera and aqueous humor. In both, aqueous humor and serum, POAG patients showed more than twofold increased reactivities for -1-Antitrypsin and Annexin V compared to healthy subjects (P≤0.001). In contrast, β-L-Crystallin showed a significantly increased mean (ME) reactivity in aqueous humor (POAG: ME=5049; SD=1638; CTRL: ME=2119; SD=673; P≤0.01) and a decreased reactivity in sera (P≤0.01) of POAG patients. For seven antigens none of the included study subjects showed immunoreactivity in aqueous humor. Using a biomarker panel of ten antibodies/antigens from each body fluid respectively, we were able to differentiate between POAG and CTRL with a specificity and sensitivity of approx. 90% (ROC-curve; serum: r=0.91; aqueous humor: r=0.93).

Conclusions: : We could confirm both up-regulations and down regulations of antibody reactivities in sera and aqueous humor of glaucoma patients, as detected in previous studies. Moreover, the increased reactivities in aqueous humor versus serum suggest a local antibody production in the eye. Nevertheless, further studies will have to proof if these observations are prevalent among all groups of glaucoma patients, e.g. normal tension glaucoma (NTG) or ocular-hypertension glaucoma (OHT).

Keywords: proteomics • discrimination 
×
×

This PDF is available to Subscribers Only

Sign in or purchase a subscription to access this content. ×

You must be signed into an individual account to use this feature.

×